Life sciences news
-
Bone Therapeutics’ allogeneic cell therapy product, ALLOB, shows 90% fusion rate at 24 months in Phase IIa study in lumbar spinal fusion
Wednesday October 14th 2020
Read more
-
Phase 2B/3 Trial shows efficacy of Filgotinib for the induction and maintenance of remission in moderately and severely active Ulcerative Colitis
Tuesday October 13th 2020
Read more
-
Sanquin finds investors for plasma-derived medicines manufacturing subsidiaries Plasma Industries and Plasma Products
Tuesday October 13th 2020
Read more
-
BISC Global awarded a Eurostars grant for the development of a machine learning based antigen discovery and T-cell epitope prediction software.
Friday October 9th 2020
Read more
-
eTheRNA strengthens senior management team with appointment of Michael Mulqueen as VP Business Development
Thursday October 8th 2020
Read more
-
Complix receives €1.2 million VLAIO grant to develop a novel and differentiated class of anti-Covid-19 Alphabody™ therapeutics
Wednesday October 7th 2020
Read more
-
CRISPRing trees for a climate-friendly economy
Wednesday October 7th 2020
Read more
-
Biocartis announces market release of SeptiCyte® RAPID test on Idylla™
Tuesday October 6th 2020
Read more
-
Become a flanders.bio member
Your news here?
-
Mithra announces FDA update
Tuesday October 6th 2020
Read more
-
argenx expands capabilities in antibody engineering through key technology partnerships
Tuesday October 6th 2020
Read more
-
Hedwig Maes appointed new CEO of Agidens
Monday October 5th 2020
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
